Loring Wolcott & Coolidge Fiduciary Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $934K | Sell |
7,395
-22
| -0.3% | -$2.9K | 0.01% | 186 |
|
|
2026
Q1 | $1.03M | Buy |
7,417
+330
| +5% | +$46.2K | 0.01% | 164 |
|
|
2025
Q4 | $999K | Hold |
7,087
| – | – | 0.01% | 166 |
|
|
2025
Q3 | $856K | Hold |
7,087
| – | – | 0.01% | 189 |
|
|
2025
Q2 | $786K | Hold |
7,087
| – | – | 0.01% | 172 |
|
|
2025
Q1 | $754K | Sell |
7,087
-1,416
| -17% | -$146K | 0.01% | 174 |
|
|
2024
Q4 | $811K | Hold |
8,503
| – | – | 0.01% | 180 |
|
|
2024
Q3 | $755K | Sell |
8,503
-168
| -2% | -$12.8K | 0.01% | 186 |
|
|
2024
Q2 | $621K | Buy |
8,671
+85
| +1% | +$5.67K | 0.01% | 190 |
|
|
2024
Q1 | $575K | Hold |
8,586
| – | – | 0.01% | 189 |
|
|
2023
Q4 | $672K | Sell |
8,586
-750
| -8% | -$58.4K | 0.01% | 184 |
|
|
2023
Q3 | $758K | Sell |
9,336
-4,491
| -32% | -$345K | 0.01% | 166 |
|
|
2023
Q2 | $1.07M | Hold |
13,827
| – | – | 0.01% | 150 |
|
|
2023
Q1 | $1.15M | Sell |
13,827
-2,801
| -17% | -$232K | 0.01% | 144 |
|
|
2022
Q4 | $1.43M | Sell |
16,628
-800
| -5% | -$63.4K | 0.02% | 131 |
|
|
2022
Q3 | $1.07M | Sell |
17,428
-98
| -0.6% | -$6.18K | 0.01% | 143 |
|
|
2022
Q2 | $1.08M | Sell |
17,526
-3,969
| -18% | -$246K | 0.01% | 148 |
|
|
2022
Q1 | $1.28M | Buy |
21,495
+4,067
| +23% | +$260K | 0.01% | 143 |
|
|
2021
Q4 | $1.26M | Buy |
17,428
+648
| +4% | +$44.6K | 0.01% | 154 |
|
|
2021
Q3 | $1.17M | Buy |
16,780
+335
| +2% | +$23.5K | 0.01% | 153 |
|
|
2021
Q2 | $1.13M | Buy |
16,445
+508
| +3% | +$33.9K | 0.01% | 162 |
|
|
2021
Q1 | $1.03M | Sell |
15,937
-671
| -4% | -$43.3K | 0.01% | 157 |
|
|
2020
Q4 | $968K | Sell |
16,608
-419
| -2% | -$25.3K | 0.01% | 160 |
|
|
2020
Q3 | $1.08M | Buy |
17,027
+450
| +3% | +$31.2K | 0.01% | 138 |
|
|
2020
Q2 | $1.27M | Buy |
16,577
+5,955
| +56% | +$456K | 0.02% | 124 |
|
|
2020
Q1 | $794K | Sell |
10,622
-1,399
| -12% | -$96.7K | 0.01% | 140 |
|
|
2019
Q4 | $781K | Sell |
12,021
-605
| -5% | -$39.4K | 0.01% | 172 |
|
|
2019
Q3 | $800K | Buy |
12,626
+778
| +7% | +$50.9K | 0.01% | 171 |
|
|
2019
Q2 | $800K | Buy |
11,848
+333
| +3% | +$21.9K | 0.01% | 171 |
|
|
2019
Q1 | $749K | Sell |
11,515
-780
| -6% | -$51.8K | 0.01% | 169 |
|
|
2018
Q4 | $769K | Sell |
12,295
-28,387
| -70% | -$1.98M | 0.01% | 167 |
|
|
2018
Q3 | $3.14M | Sell |
40,682
-143,526
| -78% | -$10.8M | 0.05% | 103 |
|
|
2018
Q2 | $13M | Sell |
184,208
-191,193
| -51% | -$13.5M | 0.23% | 67 |
|
|
2018
Q1 | $28.3M | Sell |
375,401
-54,996
| -13% | -$4.37M | 0.51% | 45 |
|
|
2017
Q4 | $30.8M | Sell |
430,397
-56,999
| -12% | -$4.33M | 0.57% | 44 |
|
|
2017
Q3 | $39.5M | Sell |
487,396
-15,288
| -3% | -$1.17M | 0.76% | 39 |
|
|
2017
Q2 | $38.2M | Sell |
502,684
-110,738
| -18% | -$7.37M | 0.76% | 41 |
|
|
2017
Q1 | $41.7M | Sell |
613,422
-101,434
| -14% | -$7.13M | 0.87% | 37 |
|
|
2016
Q4 | $51.2M | Sell |
714,856
-27,956
| -4% | -$2.08M | 1.14% | 29 |
|
|
2016
Q3 | $58.8M | Buy |
742,812
+85,737
| +13% | +$6.96M | 1.34% | 28 |
|
|
2016
Q2 | $54.8M | Buy |
657,075
+4,142
| +0.6% | +$368K | 1.26% | 29 |
|
|
2016
Q1 | $60M | Buy |
652,933
+28,531
| +5% | +$2.57M | 1.41% | 27 |
|
|
2015
Q4 | $63.2M | Buy |
624,402
+120,419
| +24% | +$12.5M | 1.56% | 26 |
|
|
2015
Q3 | $59M | Hold |
503,983
| – | – | 1.51% | 28 |
|
|
2015
Q2 | $59M | Buy |
503,983
+133,800
| +36% | +$14.6M | 1.51% | 28 |
|
|
2015
Q1 | $36.3M | Buy |
370,183
+263,993
| +249% | +$26.8M | 0.92% | 35 |
|
|
2014
Q4 | $10M | Buy |
106,190
+54,529
| +106% | +$5.64M | 0.26% | 69 |
|
|
2014
Q3 | $5.5M | Buy |
51,661
+31,660
| +158% | +$3.1M | 0.15% | 85 |
|
|
2014
Q2 | $1.66M | Buy |
20,001
+5,150
| +35% | +$401K | 0.04% | 119 |
|
|
2014
Q1 | $1.05M | Buy |
14,851
+730
| +5% | +$57.3K | 0.03% | 147 |
|
|
2013
Q4 | $1.06M | Buy |
14,121
+1,614
| +13% | +$112K | 0.03% | 145 |
|
|
2013
Q3 | $786K | Buy |
12,507
+50
| +0.4% | +$2.99K | 0.02% | 155 |
|
|
2013
Q2 | $639K | Buy |
+12,457
| New | +$649K | 0.02% | 178 |
|
Other funds holding GILD
Loring Wolcott & Coolidge Fiduciary Advisors's GILD Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors reduced its Gilead Sciences (GILD) stake by 0.3% in Q2 2026, selling an estimated $2.9K and leaving 7,395 shares worth $934K. The position accounts for 0.01% of the portfolio, ranked #186.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $63.2M in Q4 2015. 1,505 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 7,395 shares of Gilead Sciences worth $934K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
- Gilead Sciences made up 0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #186 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's Gilead Sciences position peaked at $63.2M in Q4 2015.
- 1,505 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.